VR Logo

Syngene International Ltd. download report


Healthcare | Drugs & Pharma

Syngene International Ltd. Premium Coverage

53 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

Financial Year Full AR Chairman's
Speech
Director's
Report
Management
Discussion
Corporate
Governance
Auditor's
Report
Notes to
Accounts
2022 Syngene International Ltd. Annual Report
2021 Syngene International Ltd. Annual Report Syngene International Ltd. chairman speech Syngene International Ltd. director's report Syngene International Ltd. management discussion Syngene International Ltd. corporate governance Syngene International Ltd. auditor's report Syngene International Ltd. account notes
2020 Syngene International Ltd. Annual Report Syngene International Ltd. chairman speech Syngene International Ltd. director's report Syngene International Ltd. management discussion Syngene International Ltd. corporate governance Syngene International Ltd. auditor's report Syngene International Ltd. account notes
2019 Syngene International Ltd. Annual Report Syngene International Ltd. chairman speech Syngene International Ltd. director's report Syngene International Ltd. management discussion Syngene International Ltd. corporate governance Syngene International Ltd. auditor's report Syngene International Ltd. account notes
2018 Syngene International Ltd. Annual Report Syngene International Ltd. chairman speech Syngene International Ltd. director's report Syngene International Ltd. management discussion Syngene International Ltd. corporate governance Syngene International Ltd. auditor's report Syngene International Ltd. account notes
2017 Syngene International Ltd. Annual Report Syngene International Ltd. chairman speech Syngene International Ltd. director's report Syngene International Ltd. management discussion Syngene International Ltd. corporate governance Syngene International Ltd. auditor's report Syngene International Ltd. account notes
2016 Syngene International Ltd. Annual Report Syngene International Ltd. chairman speech Syngene International Ltd. director's report Syngene International Ltd. management discussion Syngene International Ltd. corporate governance Syngene International Ltd. auditor's report Syngene International Ltd. account notes
2015 Syngene International Ltd. Annual Report Syngene International Ltd. chairman speech Syngene International Ltd. director's report Syngene International Ltd. management discussion Syngene International Ltd. corporate governance Syngene International Ltd. auditor's report Syngene International Ltd. account notes

About The Company

Business: Scientific research and development

Incorporated: 1993

Chairman: Kiran Mazumdar Shaw

Managing Director: Jonathan Hunt

Listing: BSE: 539268, NSE: SYNGENE

Country: India

Headquarters: Bengaluru, Karnataka

Website: www.syngeneintl.com

Key Facts

Market cap: ₹23,122.63 Cr

Revenue (TTM): ₹2,654.20 Cr

Earnings (TTM): ₹392.40 Cr

Cash: ₹1,281.70 Cr

Total Debt: ₹789.60 Cr

Promoters' ownership: 70.29%

Liquidity: High

52 Week range: ₹510.05 - 686.30

Face value: ₹10.00

Shares outstanding: 40,14,34,500

10 Years Aggregate:

  • CFO: ₹4,170.30 Cr
  • EBITDA: ₹4,346.90 Cr
  • Net Profit: ₹2,784.40 Cr

Stock Performance

Time Period Syngene International S&P BSE Healthcare S&P BSE Mid Cap
YTD-7.06-11.26-1.66
1 month0.505.348.60
3 months-1.671.476.17
1 Year-6.98-11.825.82
3 Years22.3122.7622.04
5 Years19.6110.869.50
10 Years--12.2714.89
As on 08-Aug-2022
Year Syngene International S&P BSE Mid Cap S&P BSE Healthcare
2021-1.9739.1820.87
202098.4519.8761.45
201914.86-3.05-3.55
20182.25-13.31-5.89
2017-3.6548.130.49
201634.517.97-12.88

Review & Analysis